Chronic News and Research

RSS

New oral drug shows promise in patients with chronic kidney disease

Patients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors (RAASI's). Although these drugs protect the heart and kidney, a significant percentage of patients develop a dangerous side effect -- high potassium levels in the blood (hyperkalemia).

31 Mar 2015

Reoccurring oxygen deprivation during pregnancy affects offspring's liver function

Sleep apnea, a disorder in which breathing repeatedly stops during sleep, is a potentially serious condition because it deprives the body of oxygen. It becomes an even more serious condition in pregnant women—who can be more prone to it—because the oxygen deprivation may affect the baby.

30 Mar 2015

COPD patients receiving home oxygen have higher risk of burn injury

Researchers from the University of Texas Medical Branch at Galveston have found that patients with chronic obstructive pulmonary disease receiving home oxygen have a higher risk of burn injury. This study was published on March 30 in Mayo Clinic Proceedings.

30 Mar 2015

Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.

30 Mar 2015

DaVita Kidney Care celebrates its dietitians and social workers

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, is celebrating its more than 3,600 dietitians and social workers during March for their distinctive and important roles in patient care.

30 Mar 2015

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

30 Mar 2015

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.

30 Mar 2015

Study: Mexican Americans spend high proportion of their later years with disability

Life expectancy for Hispanics in the U.S. currently outpaces other ethnic groups, yet a new study finds that Mexican Americans -- especially women who were born in Mexico -- are spending a high proportion of their later years with some form of disability, a fact that suggests a growing need for community assistance and long-term care in the future.

30 Mar 2015

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

Naldemedine, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) under development by Shionogi & Co., Ltd., met its primary and secondary endpoints in a phase III study (COMPOSE I) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain receiving opioid therapy.

30 Mar 2015

Experimental nanoparticle therapy speeds healing of all sorts of wounds

An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, which was successfully tested in mice, were published online in the Journal of Investigative Dermatology.

30 Mar 2015

Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania have developed two new prediction tools aimed at identifying total hip and knee replacement patients who are at-risk of developing serious complications after surgery.

30 Mar 2015

Top experts focus on musculoskeletal disorders in open key Congress in Milan

Musculoskeletal conditions, which affect over 1.7 billion people worldwide, will be the focus of a major four-day Congress which opens today in Milan, Italy.

30 Mar 2015

Discovery opens new drug development avenues for treating multiple diseases

Researchers at the University of California, San Diego School of Medicine have discovered a control switch for the unfolded protein response (UPR), a cellular stress relief mechanism drawing major scientific interest because of its role in cancer, diabetes, inflammatory disorders and several neural degenerative disorders, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's disease.

30 Mar 2015

Women face Lymphangioleiomyomatosis risk during their childbearing years

A rare and potentially deadly lung disease called Lymphangioleiomyomatosis (LAM) strikes women during their childbearing years.

29 Mar 2015

Veterans with PTSD at higher risk of developing heart failure

In a study of more than 8,000 veterans living in Hawaii and the Pacific Islands, those with posttraumatic stress disorder had a nearly 50 percent greater risk of developing heart failure over about a seven-year follow-up period, compared with their non-PTSD peers.

27 Mar 2015

Griffith research examines GPs’ confidence in providing nutritional advice to patients

The role of nutrition as part of a healthy lifestyle is well understood by the medical profession but whether this information is easily conveyed to patients is another matter. How much confidence GPs have in providing nutritional advice to their patients is now the subject of research by Griffith University’s Dr Lauren Ball.

27 Mar 2015

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced the launch and first commercial use of an updated SImmetry Sacroiliac Joint Fusion System. The surgery was performed by Dr. Brett Menmuir.

27 Mar 2015

WHO report: Access to new medicines requires transparency, collaboration

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe.

27 Mar 2015

LEO Pharma A/S announces regulatory submission of ENSTILAR® for psoriasis in Europe

ENSTILAR® has the potential to be the first cutaneous foam approved for the treatment of psoriasis vulgaris.

26 Mar 2015

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen).

From Philips Healthcare 26 Mar 2015

Chronic News and Research

New oral drug shows promise in patients with chronic kidney disease

Reoccurring oxygen deprivation during pregnancy affects offspring's liver function

COPD patients receiving home oxygen have higher risk of burn injury

Hospira announces availability of INFLECTRA (infliximab) in Canada

DaVita Kidney Care celebrates its dietitians and social workers

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Study: Mexican Americans spend high proportion of their later years with disability

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

Experimental nanoparticle therapy speeds healing of all sorts of wounds

Penn surgeons develop new tools to identify joint replacement patients at risk for serious complications

Top experts focus on musculoskeletal disorders in open key Congress in Milan

Discovery opens new drug development avenues for treating multiple diseases

Women face Lymphangioleiomyomatosis risk during their childbearing years

Veterans with PTSD at higher risk of developing heart failure

Griffith research examines GPs’ confidence in providing nutritional advice to patients

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

WHO report: Access to new medicines requires transparency, collaboration

LEO Pharma A/S announces regulatory submission of ENSTILAR® for psoriasis in Europe

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News